Experimental Type 1 Diabetes Drug Shelters Pancreas Cells From Immune System Attack

Scientists at Johns Hopkins Medicine say that an experimental monoclonal antibody drug called mAb43 appears to prevent and reverse the onset of clinical type 1

Related Keywords

Colorado ,United States ,American ,Johns Hopkins ,Aaron Michels ,Maria Golson ,Zheng Guo ,Dax Fu ,Matthew Poy ,Dylan Sarver ,Liping Yu ,Chandan Sona ,G William Wong ,Shumei Yun ,Devi Kasinathan ,Johns Hopkins University School Of Medicine ,Drug Administration ,National Institutes Of Health ,University Of Colorado ,University Of Maryland ,Johns Hopkins Medicine ,Johns Hopkins University School ,Johns Hopkins All Children ,National Institutes ,